Page last updated: 2024-08-24

triazoles and pilocarpine

triazoles has been researched along with pilocarpine in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's3 (25.00)18.2507
2000's3 (25.00)29.6817
2010's5 (41.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doughty, MJ; Lyle, WM1
Herzog, V; Miller, F1
Geyer, O; Lazar, M; Loewenstein, A; Neudorfer, M; Shalmon, B1
Carpineto, P; Ciancaglini, M; Gallenga, PE; Mastropasqua, L1
Ebinger, G; Khan, GM; Michotte, Y; Smolders, I1
Cavalheiro, EA; da Silva Fernandes, MJ; Doná, F; Ferreira, AT; Vianna, EP1
Baraldi, PG; Fenu, S; Morelli, M; Simola, N; Tabrizi, MA1
Brennum, LT; Chrobak, JJ; Collins, LE; Galtieri, DJ; Hinman, JR; Hockemeyer, J; Müller, CE; Sager, TN; Salamone, JD1
Amorim, RP; de Oliveira, DM; Fernandes, MJ; Nehlig, A; Persike, DS; Rosim, FE1
Brehme, H; Kirschstein, T; Köhling, R; Schulz, R1
Ciruela, F; Fernández-Dueñas, V; Gandía, J; Morató, X; Stagljar, I1
Bajorat, R; Goerss, D; Goßla, E; Kirschstein, T; Köhling, R; Kuhn, J; Porath, K; Sellmann, T1

Reviews

1 review(s) available for triazoles and pilocarpine

ArticleYear
A review of the clinical pharmacokinetics of pilocarpine, moxisylyte (thymoxamine), and dapiprazole in the reversal of diagnostic pupillary dilation.
    Optometry and vision science : official publication of the American Academy of Optometry, 1992, Volume: 69, Issue:5

    Topics: Adrenergic alpha-Antagonists; Humans; Iris; Moxisylyte; Phenylephrine; Pilocarpine; Piperazines; Pupil; Triazoles; Tropicamide

1992

Trials

1 trial(s) available for triazoles and pilocarpine

ArticleYear
The additive miotic effects of dapiprazole and pilocarpine.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1995, Volume: 233, Issue:7

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Miosis; Mydriasis; Ophthalmic Solutions; Parasympathomimetics; Phenylephrine; Pilocarpine; Piperazines; Pupil; Triazoles; Tropicamide

1995

Other Studies

10 other study(ies) available for triazoles and pilocarpine

ArticleYear
[The localization of endogenous peroxidase in the parotid gland of the rat].
    Zeitschrift fur Zellforschung und mikroskopische Anatomie (Vienna, Austria : 1948), 1970, Volume: 107, Issue:3

    Topics: Animals; Cytoplasmic Granules; Endoplasmic Reticulum; Golgi Apparatus; Histocytochemistry; Male; Microscopy, Electron; Microtomy; Parotid Gland; Peroxidases; Pilocarpine; Rats; Saliva; Spectrum Analysis; Triazoles

1970
The usefulness of dapiprazole, an alpha-adrenergic blocking agent, in pigmentary glaucoma.
    Ophthalmic surgery and lasers, 1996, Volume: 27, Issue:9

    Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Muscarinic Agonists; Ophthalmic Solutions; Pilocarpine; Piperazines; Prospective Studies; Timolol; Treatment Outcome; Triazoles

1996
Anticonvulsant effect and neurotransmitter modulation of focal and systemic 2-chloroadenosine against the development of pilocarpine-induced seizures.
    Neuropharmacology, 2000, Volume: 39, Issue:12

    Topics: 2-Chloroadenosine; Animals; Anticonvulsants; Behavior, Animal; Electroencephalography; Electrophysiology; Hippocampus; Injections; Male; Muscarinic Agonists; Neurotransmitter Agents; Pilocarpine; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Seizures; Triazoles

2000
Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats.
    Epilepsia, 2005, Volume: 46 Suppl 5

    Topics: 5'-Nucleotidase; Adenosine; Animals; Dentate Gyrus; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; In Situ Nick-End Labeling; Male; Neuronal Plasticity; Neuroprotective Agents; Pilocarpine; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Receptors, Purinergic P1; Status Epilepticus; Synapses; Triazoles; Xanthines

2005
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.
    Journal of the neurological sciences, 2006, Oct-25, Volume: 248, Issue:1-2

    Topics: Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Jaw; Male; Movement; Parkinson Disease; Pilocarpine; Piperazines; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Tacrine; Tremor; Triazoles

2006
Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.
    Pharmacology, biochemistry, and behavior, 2010, Volume: 94, Issue:4

    Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Jaw; Male; Muscarinic Agonists; Pilocarpine; Pimozide; Pyrimidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Tremor; Triazoles; Xanthines

2010
Differential neuroprotection by A(1) receptor activation and A(2A) receptor inhibition following pilocarpine-induced status epilepticus.
    Epilepsy & behavior : E&B, 2011, Volume: 22, Issue:2

    Topics: Adenosine; Analysis of Variance; Animals; Brain; Cell Count; Disease Models, Animal; Drug Interactions; Fluoresceins; Male; Nerve Degeneration; Neuroprotective Agents; Organic Chemicals; Phenylisopropyladenosine; Pilocarpine; Pyrimidines; Rats; Rats, Wistar; Reaction Time; Receptor, Adenosine A1; Receptor, Adenosine A2A; Status Epilepticus; Triazoles

2011
In vivo treatment with the casein kinase 2 inhibitor 4,5,6,7- tetrabromotriazole augments the slow afterhyperpolarizing potential and prevents acute epileptiform activity.
    Epilepsia, 2014, Volume: 55, Issue:1

    Topics: Animals; Anticonvulsants; CA1 Region, Hippocampal; Casein Kinase II; Disease Models, Animal; Epilepsy, Temporal Lobe; Hydrocarbons, Brominated; Male; Membrane Potentials; Patch-Clamp Techniques; Pilocarpine; Rats; Rats, Wistar; Triazoles

2014
Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.
    Behavioural brain research, 2015, Jul-15, Volume: 288

    Topics: Adenosine A2 Receptor Antagonists; Animals; Jaw; Male; Mice, Inbred C57BL; Mice, Knockout; Movement; Muscarinic Antagonists; Parkinsonian Disorders; Pilocarpine; Pyrimidines; Receptor, Adenosine A2A; Receptors, G-Protein-Coupled; Tremor; Triazoles; Tropicamide

2015
Oral administration of the casein kinase 2 inhibitor TBB leads to persistent K
    Epilepsy research, 2018, Volume: 147

    Topics: Administration, Oral; Animals; Anticonvulsants; CA1 Region, Hippocampal; Casein Kinase II; Disease Models, Animal; Electric Stimulation; Electroencephalography; Hydrocarbons, Brominated; Male; Maze Learning; Muscarinic Agonists; Neurotransmitter Agents; Pilocarpine; Potassium Channels, Calcium-Activated; Rats; Rats, Wistar; Status Epilepticus; Triazoles; Up-Regulation; Video Recording

2018